Cargando…
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
Glioblastoma (GBM) is a malignant brain tumor exhibiting rapid and infiltrative growth, with less than 10% of patients surviving over 5 years, despite aggressive and multimodal treatments. The poor prognosis and the lack of effective pharmacological treatments are imputable to a remarkable histologi...
Autores principales: | Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Tonon, Caterina, Lodi, Raffaele, Agati, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775324/ https://www.ncbi.nlm.nih.gov/pubmed/36551961 http://dx.doi.org/10.3390/biomedicines10123205 |
Ejemplares similares
-
Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
por: Gatto, Lidia, et al.
Publicado: (2021) -
Glioblastoma: Emerging Treatments and Novel Trial Designs
por: Di Nunno, Vincenzo, et al.
Publicado: (2021) -
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance
por: Di Nunno, Vincenzo, et al.
Publicado: (2022) -
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
por: Maggio, Ilaria, et al.
Publicado: (2021) -
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
por: Gatto, Lidia, et al.
Publicado: (2022)